1

Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies

hlucnkhrp0j17m
Background: KP-1461 is a prodrug to KP-1212. KP-1212 is a viral mutagen designed to increase viral error rate. Methods: We describe 2 phase I studies: KP1461-101 (double-blind. placebo-controlled. https://www.jmannino.com/limited-offer-Disney-Mickey-Mouse-Pattern-Formation-Galaxy-A14-5G-Clear-Case-p103475-top-grab/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story